608 related articles for article (PubMed ID: 25770416)
1. Molecular chaperones and neuronal proteostasis.
Smith HL; Li W; Cheetham ME
Semin Cell Dev Biol; 2015 Apr; 40():142-52. PubMed ID: 25770416
[TBL] [Abstract][Full Text] [Related]
2. Challenging Proteostasis: Role of the Chaperone Network to Control Aggregation-Prone Proteins in Human Disease.
Sinnige T; Yu A; Morimoto RI
Adv Exp Med Biol; 2020; 1243():53-68. PubMed ID: 32297211
[TBL] [Abstract][Full Text] [Related]
3. Molecular chaperones biochemistry and role in neurodegenerative diseases.
Chaari A
Int J Biol Macromol; 2019 Jun; 131():396-411. PubMed ID: 30853582
[TBL] [Abstract][Full Text] [Related]
4. Chaperones in Neurodegeneration.
Lindberg I; Shorter J; Wiseman RL; Chiti F; Dickey CA; McLean PJ
J Neurosci; 2015 Oct; 35(41):13853-9. PubMed ID: 26468185
[TBL] [Abstract][Full Text] [Related]
5. Underlying mechanisms and chemical/biochemical therapeutic approaches to ameliorate protein misfolding neurodegenerative diseases.
Hekmatimoghaddam S; Zare-Khormizi MR; Pourrajab F
Biofactors; 2017 Nov; 43(6):737-759. PubMed ID: 26899445
[TBL] [Abstract][Full Text] [Related]
6. Molecular chaperone dysfunction in neurodegenerative diseases and effects of curcumin.
Maiti P; Manna J; Veleri S; Frautschy S
Biomed Res Int; 2014; 2014():495091. PubMed ID: 25386560
[TBL] [Abstract][Full Text] [Related]
7. HSP70-HSP90 Chaperone Networking in Protein-Misfolding Disease.
Prodromou C; Aran-Guiu X; Oberoi J; Perna L; Chapple JP; van der Spuy J
Subcell Biochem; 2023; 101():389-425. PubMed ID: 36520314
[TBL] [Abstract][Full Text] [Related]
8. Protein aggregation in cell biology: An aggregomics perspective of health and disease.
Cox D; Raeburn C; Sui X; Hatters DM
Semin Cell Dev Biol; 2020 Mar; 99():40-54. PubMed ID: 29753879
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms and Functions of Spatial Protein Quality Control.
Sontag EM; Samant RS; Frydman J
Annu Rev Biochem; 2017 Jun; 86():97-122. PubMed ID: 28489421
[TBL] [Abstract][Full Text] [Related]
10. The role of HSP70 and its co-chaperones in protein misfolding, aggregation and disease.
Duncan EJ; Cheetham ME; Chapple JP; van der Spuy J
Subcell Biochem; 2015; 78():243-73. PubMed ID: 25487025
[TBL] [Abstract][Full Text] [Related]
11. DNAJ Proteins in neurodegeneration: essential and protective factors.
Zarouchlioti C; Parfitt DA; Li W; Gittings LM; Cheetham ME
Philos Trans R Soc Lond B Biol Sci; 2018 Jan; 373(1738):. PubMed ID: 29203718
[TBL] [Abstract][Full Text] [Related]
12. The Nucleolus as a Proteostasis Regulator.
Amer-Sarsour F; Ashkenazi A
Trends Cell Biol; 2019 Nov; 29(11):849-851. PubMed ID: 31473054
[TBL] [Abstract][Full Text] [Related]
13. Targeting Chaperone/Co-Chaperone Interactions with Small Molecules: A Novel Approach to Tackle Neurodegenerative Diseases.
Wang L; Bergkvist L; Kumar R; Winblad B; Pavlov PF
Cells; 2021 Sep; 10(10):. PubMed ID: 34685574
[TBL] [Abstract][Full Text] [Related]
14. Intercellular chaperone transmission via exosomes contributes to maintenance of protein homeostasis at the organismal level.
Takeuchi T; Suzuki M; Fujikake N; Popiel HA; Kikuchi H; Futaki S; Wada K; Nagai Y
Proc Natl Acad Sci U S A; 2015 May; 112(19):E2497-506. PubMed ID: 25918398
[TBL] [Abstract][Full Text] [Related]
15. The disturbance of protein synthesis/degradation homeostasis is a common trait of age-related neurodegenerative disorders.
Di Domenico F; Lanzillotta C
Adv Protein Chem Struct Biol; 2022; 132():49-87. PubMed ID: 36088079
[TBL] [Abstract][Full Text] [Related]
16. ER chaperones in neurodegenerative disease: Folding and beyond.
Garcia-Huerta P; Bargsted L; Rivas A; Matus S; Vidal RL
Brain Res; 2016 Oct; 1648(Pt B):580-587. PubMed ID: 27134034
[TBL] [Abstract][Full Text] [Related]
17. Proteostasis impairment in protein-misfolding and -aggregation diseases.
Hipp MS; Park SH; Hartl FU
Trends Cell Biol; 2014 Sep; 24(9):506-14. PubMed ID: 24946960
[TBL] [Abstract][Full Text] [Related]
18. The proteostasis network provides targets for neurodegeneration.
Newton TM; Duce JA; Bayle ED
Br J Pharmacol; 2019 Sep; 176(18):3508-3514. PubMed ID: 30820936
[TBL] [Abstract][Full Text] [Related]
19. Molecular chaperones and protein folding as therapeutic targets in Parkinson's disease and other synucleinopathies.
Ebrahimi-Fakhari D; Saidi LJ; Wahlster L
Acta Neuropathol Commun; 2013 Dec; 1(1):79. PubMed ID: 24314025
[TBL] [Abstract][Full Text] [Related]
20. Molecular Chaperones in Neurodegenerative Diseases: A Short Review.
Bobori C; Theocharopoulou G; Vlamos P
Adv Exp Med Biol; 2017; 987():219-231. PubMed ID: 28971461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
